StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Zomedica's operating income for the twelve months ending Jun 30, 2026 was -$20.75M. For fiscal 2025 it was -$84.35M. The highest annual figure on record is -$5.73M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$84.35M–
FY2024Dec 31, 2024-$51.05M–
FY2023Dec 31, 2023-$43.28M–
FY2022Dec 31, 2022-$21.92M–
FY2021Dec 31, 2021-$21.37M–
FY2020Dec 31, 2020-$16.76M–
FY2019Dec 31, 2019-$19.78M–
FY2018Dec 31, 2018-$16.58M–
FY2017Dec 31, 2017-$8.08M–
FY2016Dec 31, 2016-$5.73M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.08M–
Q1 FY2026Mar 31, 2026-$4.90M–
Q4 FY2025Dec 31, 2025-$5.16M–
Q3 FY2025Sep 30, 2025-$6.61M–
Q2 FY2025Jun 30, 2025-$8.04M–
Q1 FY2025Mar 31, 2025-$64.55M–
Q4 FY2024Dec 31, 2024-$8.16M–
Q3 FY2024Sep 30, 2024-$7.44M–
Q2 FY2024Jun 30, 2024-$25.07M–
Q1 FY2024Mar 31, 2024-$10.39M–
Q4 FY2023Dec 31, 2023-$23.07M–
Q3 FY2023Sep 30, 2023-$5.95M–
Q2 FY2023Jun 30, 2023-$6.74M–
Q1 FY2023Mar 31, 2023-$7.51M–
Q4 FY2022Dec 31, 2022-$5.14M–
Q3 FY2022Sep 30, 2022-$6.59M–
Q2 FY2022Jun 30, 2022-$5.88M–
Q1 FY2022Mar 31, 2022-$4.31M–
Q4 FY2021Dec 31, 2021-$5.77M–
Q3 FY2021Sep 30, 2021-$6.41M–
Q2 FY2021Jun 30, 2021-$5.33M–
Q1 FY2021Mar 31, 2021-$3.87M–
Q4 FY2020Dec 31, 2020-$4.13M–
Q3 FY2020Sep 30, 2020-$5.00M–
Q2 FY2020Jun 30, 2020-$5.30M–
Q1 FY2020Mar 31, 2020-$2.33M–
Q4 FY2019Dec 31, 2019-$2.86M–
Q3 FY2019Sep 30, 2019-$2.84M–
Q2 FY2019Jun 30, 2019-$2.39M–
Q1 FY2019Mar 31, 2019-$11.69M–
Q4 FY2018Dec 31, 2018-$8.42M–
Q3 FY2018Sep 30, 2018-$1.85M–
Q2 FY2018Jun 30, 2018-$4.15M–
Q1 FY2018Mar 31, 2018-$2.17M–
Q4 FY2017Dec 31, 2017-$2.56M–
Q3 FY2017Sep 30, 2017-$2.09M–
Q2 FY2017Jun 30, 2017-$1.59M–
Q1 FY2017Mar 31, 2017-$1.85M–

More Zomedica figures

See a number that looks wrong?